Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.

Hebert, Adelaide A; Glaser, Dee Anna; Green, Lawrence; Hull, Cheryl; Cather, Jennifer; Drew, Janice; Gopalan, Ramanan; Pariser, David M

Hebert, Adelaide A; Glaser, Dee Anna; Green, Lawrence; Hull, Cheryl; Cather, Jennifer; Drew, Janice; Gopalan, Ramanan; Pariser, David M.

Afiliação

Hebert AA; UTHealth McGovern Medical School, Houston, Texas, United States.
Glaser DA; Saint Louis University, St. Louis, Missouri, United States.
Green L; George Washington University School of Medicine, Washington, District of Columbia, United States.
Hull C; Northwest Arkansas Clinical Trials Center, PLLC, Rogers, Arkansas.
Cather J; Modern Research Associates, PLLC, Dallas, Texas, United States.
Drew J; Dermira, Inc., Menlo Park, California, United States.
Gopalan R; Dermira, Inc., Menlo Park, California, United States.
Pariser DM; Eastern Virginia Medical School, Virginia Clinical Research, Inc., Norfolk, Virginia, United States.

Pediatr Dermatol ; 37(3): 490-497, 2020 May.

Article em En | MEDLINE | ID: mdl-32147881

Assuntos

Glicopirrolato; Hiperidrose; Axila; Criança; Antagonistas Colinérgicos; Método Duplo-Cego; Glicopirrolato/efeitos adversos; Humanos; Hiperidrose/tratamento farmacológico; Resultado do Tratamento

Palavras-chave

anticholinergic; axilla; glycopyrronium tosylate; hyperhidrosis; sweat

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicopirrolato / Hiperidrose Tipo de estudo: Clinical_trials Limite: Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google